Latest News
WCG Acquires eClinical Software Provider VeraSci
Tuesday 27 July 2021

US-based clinical services company WCG has acquired US-based specialty scientific expertise and eClinical software provider VeraSci, the company said.

VeraSci solutions support the design and execution of clinical trials focused on central nervous system disorders.

The addition of VeraSci, based in Durham, North Carolina, deepens WCG's scientific and patient engagement capabilities, and complements its CNS offerings, including those available via the company's MedAvante, ProPhase and Analgesic Solutions businesses.

With this expansion, WCG said it is addressing the growing demand for proven scientific and technology solutions to power remote data capture, hybrid virtual studies and fully decentralized clinical trials in key CNS therapeutic areas.

VeraSci provides clients around the world with solutions that improve data quality in clinical trials, including endpoint and assessment services, rater training and certification, language and translation support, and eCOA and ePRO technologies.

With its Pathway technology platform, VeraSci enables the collection of data that can be used to assess symptoms, cognition and functional capacity in a wide range of therapeutic indications.

VeraSci is a clinical research company offering eClinical software, translation services, and expertise in endpoints and assessments.
Date Published: 27/07/2021